- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00552890
Modified Atkins Diet and Type 2 Diabetic Patients
November 1, 2007 updated by: Hadassah Medical Organization
Influende of a Modified Atkins Diet on Glucose Metabolism and Weight Loss in Obese Type 2 Diabetic Patients - A Randomized Controlled Trial
This randomized control trial compared the influence of an Atkins diet to that of the ADA recommended diet on Type 2 diabetic obese patients during a one-year follow-up period
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Type 2 diabetic patients age 35-75 years
- BMI 30-39.9kg/m
- HbA1C>7%
- Not receiving insulin
- Micro-albumin excretion<60 mg/day
Exclusion Criteria:
- Serum creatinine level > 1.4 mg per deciliter
- Diastolic blood pressure > 100 mmHg or systolic blood pressure > 180mmHg
- Liver disease
- LDL cholesterol > 160 mg per deciliter despite lipid-lowering treatment
- Use of psychiatric medications
- Osteoporosis
- Cancer
- Food allergies, and
- Low carbohydrate diet in the past 6 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ATK
modified Atkins diet
|
subjects assigned to follow modified Atkins diet for 1 year
|
|
Experimental: ADA
subjects assigned to follow ADA recommended diet for 1 year
|
subjects assigned to follow ADA recommended diet for period of 1 year
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
weight loss and glucose control
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
lipid profile, kidney function
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Itamar Raz, MD, Director, Diabetes Unit, Hadassah University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2001
Study Completion (Actual)
February 1, 2004
Study Registration Dates
First Submitted
November 1, 2007
First Submitted That Met QC Criteria
November 1, 2007
First Posted (Estimate)
November 2, 2007
Study Record Updates
Last Update Posted (Estimate)
November 2, 2007
Last Update Submitted That Met QC Criteria
November 1, 2007
Last Verified
December 1, 2001
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- atkins-hmo-ctil
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.